'GI-4000 will now be evaluated in combination with multiple additional agents in patients with Head and Neck Cancer.'
- Forums
- ASX - By Stock
- Globeimmune
'GI-4000 will now be evaluated in combination with multiple...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)